| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.43B | 15.51B | 15.16B | 14.18B | 14.27B | 12.14B |
| Gross Profit | 2.89B | 2.46B | 2.48B | 816.69M | 1.60B | 1.26B |
| EBITDA | 6.57B | 6.20B | 6.14B | 5.05B | 6.25B | 5.67B |
| Net Income | 956.45M | 414.48M | 5.11B | 146.64M | 876.04M | 882.83M |
Balance Sheet | ||||||
| Total Assets | 73.98B | 77.44B | 77.93B | 71.35B | 71.56B | 74.44B |
| Cash, Cash Equivalents and Short-Term Investments | 8.12B | 6.97B | 9.23B | 4.41B | 4.38B | 4.49B |
| Total Debt | 42.44B | 44.01B | 45.54B | 44.69B | 48.02B | 53.39B |
| Total Liabilities | 49.42B | 51.35B | 52.87B | 51.99B | 53.67B | 59.32B |
| Stockholders Equity | 24.57B | 26.09B | 25.06B | 19.37B | 17.89B | 15.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -607.48M | -1.38B | 2.79B | 3.22B | -3.48B |
| Operating Cash Flow | 0.00 | 5.54B | 4.71B | 6.04B | 4.92B | 6.03B |
| Investing Cash Flow | 0.00 | -5.44B | -2.14B | -2.61B | 433.47M | -5.62B |
| Financing Cash Flow | 0.00 | -1.91B | 565.29M | -3.49B | -5.53B | 2.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥185.46B | 7.13 | 13.08% | 3.75% | -7.12% | 29.40% | |
72 Outperform | ¥1.57T | 12.54 | 11.32% | 5.12% | -2.82% | -54.04% | |
65 Neutral | ¥21.02B | 6.04 | ― | 1.29% | 1.42% | 88.77% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | ¥2.07T | 17.02 | 10.90% | 5.81% | 2.80% | -47.61% | |
54 Neutral | ¥159.45B | 12.04 | ― | 4.08% | -10.27% | -16.20% | |
47 Neutral | ¥10.29B | 38.42 | ― | 5.77% | 2.31% | -91.89% |